Singapore scientists track genetic changes to speed up testing for coronavirus vaccines

Currently, there are no medicines or preventive vaccines targeting the virus, with most patients receiving only supportive care.

Reuters March 25, 2020 14:50:50 IST
Singapore scientists track genetic changes to speed up testing for coronavirus vaccines

Scientists in Singapore say they have developed a way to track genetic changes that speeds testing of vaccines against a coronavirus that has killed more than 16,000 people worldwide.

The scientists, at the city-state’s Duke-NUS Medical School, say their technique needs just days to evaluate potential vaccines provided by Arcturus Therapeutics, an American biotech firm the school has partnered with for the trials.

That timeframe compares with the months usually required for testing based on human responses.

Singapore scientists track genetic changes to speed up testing for <span class=coronavirus vaccines" width="1280" height="720" />

Currently there are no treatments or preventive vaccines that target the virus . Image by Наркологическая Клиника from Pixabay.

“You can know from the way the genes change - what genes are turned on, what are turned off,” said Ooi Eng Eong, deputy director of the school’s emerging infectious diseases program.

Swift assessment of such changes triggered by a vaccine allows the scientists to determine its effectiveness and side effects, instead of relying solely on responses from humans who receive it, he added.

Currently, there are no approved medicines or preventive vaccines targeting the virus, with most patients receiving only supportive care, such as help with their breathing. Experts have said getting a vaccine ready could take a year or more.

Ooi said he planned to start testing vaccines in mice in about a week, with human trials expected in the second half of the year.

Pharmaceutical firms and researchers around the globe are racing to develop vaccines and treatments for the virus, which has infected more than 377,000 people.

These efforts include Gilead Sciences Inc’s experimental antiviral drug remdesivir and a plasma-derived therapy from Japan’s Takeda Pharmaceutical Co.

In a key step towards developing diagnostic methods, the Duke-NUS scientists helped culture the virus in late January, days after Singapore confirmed its first infection. That made it the third country, outside China, to culture the virus.

Another first was a test to detect virus antibodies even in those who had already recovered, crucial in containment efforts that have won global praise for Singapore.

From discovery to licensing, vaccine development in the past could take more than 10 years, but Ooi said science can now offer a much faster response.

“Everyone is racing ahead, but we are kind of writing the playbook as the game is being played,” he added.

Updated Date:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Won't allow sale of Patanjali's Coronil in Maharashtra without 'proper certification', says Anil Deshmukh
India

Won't allow sale of Patanjali's Coronil in Maharashtra without 'proper certification', says Anil Deshmukh

The statement comes a day after the IMA demanded an explanation from the Union health minister for 'promoting' CORONIL as a cure for COVID-19

India reports 10,584 new COVID-19 cases, 78 fatalities in a day; tally crosses 1.1 cr
Health

India reports 10,584 new COVID-19 cases, 78 fatalities in a day; tally crosses 1.1 cr

The active coronavirus cases in the country have reduced to 1,47,306 which comprises 1.34 percent of the total caseload, said the health ministry

India registers 13,993 new COVID-19 cases, highest in 22 days; active caseload stays below 1.5 lakh
Health

India registers 13,993 new COVID-19 cases, highest in 22 days; active caseload stays below 1.5 lakh

The number of people who have recuperated from the coronavirus surged to 1,06,78,048 taking the national recovery rate to 97.27 percent, said the health ministry